RxDoctor Payments Data

John Trayer, DO

Child & Adolescent Psychiatry · Chambersburg, PANPI 1750555488

Payments from drug & device makers

$806in general payments, 2019–2025

Across 44 payments — averaging $18.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$536
  • Corium, LLC$87
  • Alkermes, Inc.$59
  • Neuronetics, Inc.$51
  • Otsuka America Pharmaceutical, Inc.$22
  • Shire North American Group Inc$20
  • plus $30 from 2 others

What the payments were for

  • Food & beverage$806100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$806 in reported general payments places this provider in the 65th percentile of 200 child & adolescent psychiatry providers in Pennsylvania.

See all child & adolescent psychiatry providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$30,084
Medicare patients
31
Services billed
264

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl13$18,324
Lurasidone Hcl20$3,712
Ziprasidone Hcl29$1,059
Paroxetine Hcl79$683
Fluvoxamine Maleate26$659
Lamotrigine99$648
Buspirone Hcl42$569
Doxepin Hcl13$475
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine13$470
Methylphenidate ErMethylphenidate Hcl12$469
Gabapentin27$439
Sertraline Hcl37$418
Venlafaxine Hcl ErVenlafaxine Hcl39$391
Bupropion Hcl SrBupropion Hcl42$311
Quetiapine Fumarate54$306

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$16$18,32413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 200 child & adolescent psychiatry providers in Pennsylvania.

Other child & adolescent psychiatry in Chambersburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →